TrialBMC cancer2006

A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma.

Kazuma Kobayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.